Skip to main content

Table 6 Numbers assessed at each time period in each treatment group

From: The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI

  Control Patient     
   Any High Risk Low Risk
    XRT HDM HDM IT MTX
Any test 311 555 77 79 202 197
5 month test 161 305 47 42 104 112
3 year test 173 369 51 45 139 134
5 year test 132 289 34 35 116 104
5 month only 92 133 23 28 35 47
3 year only 57 94 15 16 34 29
5 year only 37 40 3 6 21 10
5 month and 3 year only 30 39 5 0 17 17
5 month and 5 year only 9 13 0 0 7 6
3 year and 5 year only 56 116 12 15 43 46
All 3 tests 30 120 19 14 45 42